EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

• Main Authors: Bao, Y., Oguz, G., Lee, W.C., Lee, P.L., Ghosh, K., Li, J., Wang, P., Lobie, P.E., Ehmsen, S., Ditzel, H.J., Wong, A., Tan, E.Y., Lee, S.C., Yu, Q.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: Nature Research 2021
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/199286
• Institution: National University of Singapore

10.1038/s41467-020-19704-x